← Evidence map

SynthesisPulmonology

Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review.

A Cortegiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

92 papers cite itlatest 60 shown

2021
2022
2023
2024
2025
2026
pooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32713784